Vertex Pharma poised to dominate global gene therapy market with first CRISPR approval: GlobalData Read more
Verve’s gene-editing therapy trial to lower cholesterol levels opens doors for use in CVDs: GlobalData Read more
First-in-class DLL3-targeting BiTE could be the next big player in SCLC treatment: GlobalData Read more